ReviewMolecular biomedicine2026
The role of ubiquitin system in ageing-related diseases and potential therapeutic opportunities.
Review in Molecular biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Ubiquitination functions significantly in ageing, contributing to its influences on ageing-related diseases. Being one of the important posttranslational modifications, ubiquitination can make a difference to the stabilization of diverse proteins, which can be reversed by deubiquitinases (DUBs). The mechanisms of ageing such as loss of proteostasis, mitochondrial dysfunction are gradually illustrated and researchers' attention on ageing-related diseases including cancers is increasing. The association between ubiquitin proteasome system (UPS) and DUBs with cellular ageing and ageing-related diseases are gradually demonstrated while not comprehensively reviewed. In this review, we illustrate the relationship between ubiquitin system with ageing and provide a further introduction of roles of ubiquitin system in ageing-related diseases. To begin with, the fundamentals of ubiquitin system including the ligases, deubiquitinases and processes of ubiquitination/deubiquitination are given. Then, association between ubiquitin and cellular ageing is further discussed. Besides, we concentrate on the detailed roles of deubiquitination in ageing-related diseases, potential therapeutic targets of the ubiquitin system in ageing-related diseases and the relevant clinical trials so that we can have a comprehensive perspective of the clinical potentials of ubiquitin system in ageing-related diseases. In summary, the information concluded here may be assistant for further investigation in ageing-related diseases in the future.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.